New pill aims to restore skin color in vitiligo patients

This study tests an experimental pill called LW402 in 180 adults with non-segmental vitiligo, a condition that causes white patches on the skin. The pill works by blocking certain immune signals. Participants will take one of three doses or a placebo for up to 52 weeks to see if it helps bring back skin color, especially on the face. The goal is to find a safe and effective treatment to control the disease.